erythromycin has been researched along with glycerol in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (58.82) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Kloos, WE; Schleifer, KH | 1 |
| Camougrand, N; Guerin, M; Velours, G | 1 |
| Geary, C; Stevens, M | 1 |
| Almazan, J; de la Fuente, R; Freney, J; Gomez-Lucia, E; Suarez, G | 1 |
| Brown, RD; Henley, CM; Kupetz, S; Penny, JE | 1 |
| Arias-Saavedra, JM; Machado, A; Mayor, F; Nuñez de Castro, I | 1 |
| Clegg, RA; Garland, PB | 1 |
| Wallis, OC; Whittaker, PA | 1 |
| Cryer, DR; Goldthwaite, CD; Marmur, J | 1 |
| Luha, AA; Sarcoe, LE; Whittaker, PA | 1 |
| Meshcheryakova, IS; Olsufjev, NG | 1 |
| Arimura, K; Higuchi, I; Izumo, S; Kawabata, M; Kubota, H; Maruyama, Y; Nakagawa, M; Nakahara, K; Osame, M | 1 |
| Gurycová, D | 1 |
| Kataoka, M; Masaoka, Y; Sakuma, S; Yamashita, S; Yokoyama, T | 1 |
| Jiang, M; Pfeifer, BA | 1 |
1 review(s) available for erythromycin and glycerol
| Article | Year |
|---|---|
Link between functional and morphological changes in the inner ear--functional changes produced by ototoxic agents and their interactions.
Topics: Acetylcysteine; Adult; Aminoglycosides; Aminooxyacetic Acid; Anesthetics; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Aspirin; Child; Chloramphenicol; Cochlea; Cochlear Microphonic Potentials; Diuretics; Drug Synergism; Erythromycin; Evoked Potentials, Auditory; Glycerol; Guinea Pigs; Hair Cells, Auditory; Hearing Loss, Sensorineural; Humans; Labyrinth Diseases; Noise; Otitis Media; Rats; Stria Vascularis | 1985 |
1 trial(s) available for erythromycin and glycerol
| Article | Year |
|---|---|
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antiviral Agents; Ascorbic Acid; Azathioprine; Danazol; Erythromycin; Estrogen Antagonists; Female; Fosfomycin; Glycerol; Human T-lymphotropic virus 1; Humans; Hydrocortisone; Immunoglobulins, Intravenous; Immunosuppressive Agents; Injections, Intramuscular; Injections, Intravenous; Injections, Spinal; Interferon-gamma; Leukapheresis; Male; Methylprednisolone; Middle Aged; Paraparesis, Tropical Spastic; Pentoxifylline; Plasmapheresis; Propiophenones; Respiratory Therapy; Ribonucleosides; Sulfasalazine; Thyrotropin-Releasing Hormone; Vasodilator Agents | 1996 |
15 other study(ies) available for erythromycin and glycerol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A simple test system for the separation of staphylococci from micrococci.
Topics: Acids; Aerobiosis; Bacteriological Techniques; Drug Resistance, Microbial; Erythromycin; Glycerol; Humans; Lysostaphin; Micrococcus; Muramidase; Skin; Species Specificity; Staphylococcus | 1975 |
Biochemical studies carried out on different groups of Candida parapsilosis and Candida rhagii strains by comparing some cellular and mitochondrial activities.
Topics: 1-Propanol; Alcohol Dehydrogenase; Antimycin A; Candida; Diuron; Drug Resistance, Microbial; Erythromycin; Glucose; Glycerol; Mitochondria; Oxygen Consumption; Paromomycin; Propanols | 1991 |
Rapid lysostaphin test to differentiate Staphylococcus and Micrococcus species.
Topics: Bacteriological Techniques; Bacteriolysis; Drug Resistance, Microbial; Erythromycin; Glycerol; Lysostaphin; Micrococcus; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis | 1986 |
Comparison of methods for routine separation of coagulase-negative staphylococci from micrococci isolated from sheep.
Topics: Animals; Bacterial Infections; Bacteriolysis; Coagulase; Culture Media; Erythromycin; Glucose; Glycerol; Lysostaphin; Micrococcus; Muramidase; Sheep; Sheep Diseases; Staphylococcal Infections; Staphylococcus | 1986 |
Effect of inhibitors of mitochondrial protein synthesis on the NADH and NADPH glutamate dehydrogenases in yeast.
Topics: Acetates; Aerobiosis; Cell-Free System; Chloramphenicol; Erythromycin; Gluconates; Glucose; Glutamate Dehydrogenase; Glycerol; Kinetics; Mitochondria; NAD; NADP; Oxytetracycline; Saccharomyces cerevisiae; Ultrasonics | 1974 |
Non-haem iron and the dissociation of piericidin A sensitivity from site 1 energy conservation in mitochondria from Torulopsis utilis.
Topics: Chloramphenicol; Cycloheximide; Cytochromes; Electron Transport; Energy Transfer; Erythromycin; Flavoproteins; Glycerol; Heme; Iron; Iron Isotopes; Malates; Mitochondria; Mitosporic Fungi; NAD; Oxygen Consumption; Proteins; Pyridines; Pyruvates; Rotenone; Sulfur; Tetracycline; Time Factors | 1971 |
Induction of petite mutation in yeast by starvation in glycerol.
Topics: Centrifugation, Density Gradient; Cycloheximide; DNA; Erythromycin; Ethidium; Glycerol; Mitochondria; Mutagens; Mutation; Nalidixic Acid; Oxygen Consumption; Rifampin; Saccharomyces cerevisiae | 1974 |
Effect of carbon source on the replication and transmission of yeast mitochondrial genomes.
Topics: Carbon; Crosses, Genetic; Culture Media; DNA; DNA, Mitochondrial; Drug Resistance, Microbial; Erythromycin; Extrachromosomal Inheritance; Genetics, Microbial; Glucose; Glycerol; Mitochondria; Molecular Biology; Oligomycins; Recombination, Genetic; Saccharomyces cerevisiae | 1974 |
Biosynthesis of yeast mitochondria. Drug effects on the petite negative yeast kluyveromyces lactis.
Topics: Acridines; Chloramphenicol; DNA; Erythromycin; Genetics, Microbial; Glucose; Glycerol; Mitochondria; Mutation; Nalidixic Acid; Oxygen Consumption; Phenanthridines; Saccharomyces; Ultracentrifugation | 1971 |
Infraspecific taxonomy of tularemia agent Francisella tularensis McCoy et Chapin.
Topics: Agglutination Tests; Animals; Citrulline; Ecology; Erythromycin; Francisella tularensis; Glycerol; Humans; Rabbits | 1982 |
First isolation of Francisella tularensis subsp. tularensis in Europe.
Topics: Animals; Animals, Wild; Anti-Bacterial Agents; Asia; Canada; Citrulline; Erythromycin; Europe; Francisella tularensis; Glucose; Glycerol; Guinea Pigs; Humans; Mammals; Mice; Mites; Population Surveillance; Rabbits; Serotyping; Siphonaptera; Slovakia; Ticks; Tularemia; United States; Virulence; Zoonoses | 1998 |
Estimation of P-glycoprotein-mediated efflux in the oral absorption of P-gp substrate drugs from simultaneous analysis of drug dissolution and permeation.
Topics: Algorithms; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Drug Interactions; Erythromycin; Gene Expression; Glycerol; Humans; Intestinal Absorption; Loperamide; Models, Biological; Pharmaceutical Preparations; Propanolamines; Puromycin; Quinidine; Saquinavir; Solubility; Surface-Active Agents; Terfenadine; Verapamil; Vinblastine | 2011 |
Metabolic and pathway engineering to influence native and altered erythromycin production through E. coli.
Topics: Acyl Coenzyme A; Erythromycin; Escherichia coli; Glycerol; Metabolic Engineering | 2013 |